IGNT looks to be mounting a bounce of some sort. The company posted it's quarterly filing at Pink Sheets overnight. Revenues are on the rise. The company does have a substantial amount of debt compared to cash on hand, which is something to be wary about that. (News Out This Morning Pasted Below)
UNDT posted news this morning (pasted below). The stock could see a pop early in the session.
Universal Detection Technology Anthrax Detection Equipment Approved on New York State H.I.R.E. Contract, Distributed by Strategic Response Initiatives Market Wire "US Press Releases "
LOS ANGELES, CA -- (MARKET WIRE) -- 10/20/09 -- Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced yesterday that it is preparing for inclusion in the H.I.R.E. (Hazardous Incident Response Equipment) contract, a special IDIQ contract vehicle established in New York State post 9/11.
" Universal Detection Technology's addition to H.I.R.E. allows states and municipalities to quickly equip first responders and law enforcement agencies with the tools needed to combat bioterrorism threats," said Jacques Tizabi , CEO of Universal Detection Technology . "By including UNDT's handheld bio-weapons detection kits in the H.I.R.E comprehensive catalog, we are not only saving vital monetary resources and time spent on individual procurement requests, but we are also rapidly and efficiently supplying the vital resources needed to keep the public safe," continued Tizabi.
UNDT's addition to H.I.R.E. has been approved by the contract manager for New York State's Office of General Services and is pending final approval from the State's Comptroller.
As an H.I.R.E. product, Universal Detection Technology's 5 agent biodetection kits will be available through current UNDT distributor Strategic Response Initiatives, a New York based defense firm specializing in all phases of emergency preparedness planning for a wide range of defense contracts, public and private sector organizations. SRI's customers include Department of Homeland Security , U.S. State Department , U.S. Marine Corps Chemical Biological Incident Response Force (CBIRF) and NATO forces in Afghanistan .
SRI's founder and CEO Robert L. Domenici , a retired U.S. Army lieutenant colonel, is credited with charting H.I.R.E. in 2005 while he served on the WMD Task Force . Established in the wake of September 11th , H.I.R.E. addresses the problems associated with numerous individual procurement requests requiring sensitive grant money for approved products. With H.I.R.E., state and municipal entities can procure equipment without a formalized bid process, resulting in discounted manufacturer costs and a comprehensive, ready-to-order catalog contract with a variety of products, manufacturers and competitive pricing.
In addition to New York State , the contract is reciprocal in 14 other states, including California , Virginia , Massachusetts , Florida and Arizona .
Universal Detection Technology's kits, recently certified by DHS as an "Approved Product for Homeland Security" under the Support Anti-terrorism by Fostering Effective Technologies (SAFETY) Act of 2002, are the industry's only hand-held assay designed to detect and identify up to five separate threats using one sample in a single, easy-to-use device. The kits equip first responders with an effective tool for the rapid onsite detection of up to five biological warfare agents: anthrax, ricin, botulinum toxin, Y. pestis (plague) and Staphylococcal Enterotoxin B (SEB). Detection time is under three minutes.
For more information, please visit www.udetection.com or email info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, Universal Detection Technology , in cooperation with NASA , has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
About Strategic Response Initiatives (SRI)
Strategic Response Initiatives, LLC (SRI) was initially organized in November of 2005 as a Limited Liability Corporation providing procurement and domestic disaster preparedness training services; As a logical outgrowth of these activities, SRI now assists and supplies various military, firefighting, police, emergency medical services (EMS) and other First Responder organizations worldwide, with their critical equipment, equipment support, equipment specific training, tactical training and information technology needs.
SRI is seeking to become the leading integrator of proven and emerging technologies in the area of specialized logistics management, security assistance and training as well as environmental and disaster preparedness equipment systems and training for military, government and corporate use. www.strategicri.com.
Contacts Media Contact(s): The Pollack PR Marketing Group Stefan Pollack / Jonathan Younger 310-556-4443 Email Contact Email Contact Company Contact: Universal Detection Technology Jacques Tizabi 310-248-3655 Email Contact
Ingen CEO Discusses Company Future on Live Radio GlobeNewswire "GlobeNewswire "
YUCAIPA, Calif. , Oct. 20, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that Scott Sand , CEO of Ingen Technologies , will talk about Ingen's future on the live radio broadcast of The Money Channel's American Scene Radio scheduled for this morning at 9:42 a.m. For more information, go to http://www.moneychannel.tv/
" Ingen is growth oriented, and we have a spectacular 2010 ahead of us. With the introduction of our new Oxyview Nasal cannula, Ingen is establishing footsteps in the world of medical technology. We will have a series of live radio broadcasts scheduled from now through the middle of next year," stated Scott R. Sand , Chief Executive Officer and Chairman of the Board.
http://www.moneychannel.tv/
www.ingen-tech.com
About Ingen :
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration , and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009, the company introduced the new Oxyview Nasal Cannula for adult, children and infants. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California , Department of Public Health , Food and Drug Branch as it manufacturers all of its respiratory products in the United States . There are 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission .
CONTACT: Ingen Technologies, Inc. Jeff Morgan 909-790-7180 www.info@ingen-tech.com
Posts
3 comments:
Guru some people are saying there is massive dilution occuring in DLAD, considering I bought yesterday I am wondering what you think is going on with the stock?
I noted the reverse split and said to be wary in my alert. Dilution is an aspect with these sub-penny stocks that is neither pleasant or acceptable. It is the reason why you never hold most of them for more than a few days. DLAD volume is rather light today, it could be people holding stock from lower prices. More likely its a mix of both dilution and profit taking.
Are YOU IMPATIENT? This was the best thing I ever did! You can get stock picks days before everyone else!!! Just copy and past the following link.
http://ebe297xg8fkh2ue4t8j3exevf7.hop.clickbank.net/
Post a Comment